Autor: |
Nicholas Weight, Saadiq Moledina, Mohsin Ullah, Harindra C. Wijeysundera, Simon Davies, Nicholas W. S. Chew, Claire Lawson, Safi U. Khan, Chris P. Gale, Muhammad Rashid, Mamas A. Mamas |
Jazyk: |
angličtina |
Rok vydání: |
2024 |
Předmět: |
|
Zdroj: |
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 16 (2024) |
Druh dokumentu: |
article |
ISSN: |
2047-9980 |
DOI: |
10.1161/JAHA.123.032671 |
Popis: |
Background A growing population of patients with chronic kidney disease (CKD) presents with non–ST‐segment–elevation myocardial infarction, although little is known about their longer‐term mortality. Methods and Results Using the MINAP (Myocardial Ischaemia National Audit Project) registry, linked to Office for National Statistics mortality data, we analyzed 363 559 UK patients with non–ST‐segment–elevation myocardial infarction, with or without CKD. Cox regression models were fitted, adjusting for baseline demographics. Compared with patients without CKD, patients with CKD were less frequently prescribed P2Y12 inhibitors (89% versus 86%, P |
Databáze: |
Directory of Open Access Journals |
Externí odkaz: |
|